BioSign® Flu A + B
1 / 1Pages

An in vitro rapid qualitative test that detects influenza type A and type B antigens directly from nasal swab, nasopharyngeal swab and nasal aspirate/wash specimens* SIMPLE PROCEDURE1 FOR SWAB SPECIMENS Differentiates between Influenza A and B EXTRACT Fill extraction well with reagent. INCUBATE Insert collection swab and incubate for 1 minute. FLIP Tip device for 1-2 seconds allowing liquid to flow. READ RESULTS IN 10 TO 15 MINUTES. POSITIVE AND NEGATIVE CONTROL SWABS READING RESULTS 1 VALID TEST RESULTS NEGATIVE INNOVATIVE FLIP DESIGN WITH ONBOARD SAMPLE EXTRACTION PRE-MEASURED DEVELOPER SOLUTION CAPSULE for increased accuracy and ease of use FLOCKED NASAL SWABS for improved patient comfort and superior specimen collection INVALID TEST RESULTS A LINE: Influenza type A B LINE: Influenza type B A & B LINE: Influenza type A & B Repeat with new sample and device. PROVEN CLINICAL PERFORMANCE (BioSign® Flu A & B vs, PCR) POSITIVE % AGREEMENT NEGATIVE % AGREEMENT THE TESTS YOU WANT. THE ACCURACY YOU NEED! ©2019 Germaine Laboratories, Inc., CSM 0800-31 , Rev. 01-19 * CPT reimbursements vary, check your state for current amounts 1 See Package Insert for complete details. Check with each state for exact reimbursement. • Nasal Aspirate Specim